HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/2/H541    most recent 01113.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Gilbert, J. S. Articles by Granger, J. P. Search for Related Content PubMed PubMed Citation Articles by Gilbert, J. S. Articles by Granger, J. P.

INVITED REVIEW

Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction

Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Mississippi

Studies over the last decade have provided exciting new insights into potential mechanisms underlying the pathogenesis of preeclampsia. The initiating event in preeclampsia is generally regarded to be placental ischemia/hypoxia, which in turn results in the elaboration of a variety of factors from the placenta that generates profound effects on the cardiovascular system. This host of molecules includes factors such as soluble fms-like tyrosine kinase-1, the angiotensin II type 1 receptor autoantibody, and cytokines such as tumor necrosis factor-, which generate widespread dysfunction of the maternal vascular endothelium. This dysfunction manifests as enhanced formation of factors such as endothelin, reactive oxygen species, and augmented vascular sensitivity to angiotensin II. Alternatively, the preeclampsia syndrome may also be evidenced as decreased formation of vasodilators such as nitric oxide and prostacyclin. Taken together, these alterations cause hypertension by impairing renal pressure natriuresis and increasing total peripheral resistance. Moreover, the quantitative importance of the various endothelial and humoral factors that mediate vasoconstriction and elevation of arterial pressure during preeclampsia remains to be elucidated. Thus identifying the connection between placental ischemia/hypoxia and maternal cardiovascular abnormalities in hopes of revealing potential therapeutic regimens remains an important area of investigation and will be the focus of this review.

kidney; pregnancy; nitric oxide; vascular endothelial growth factor; cytokines

This article has been cited by other articles:

				S. D. Smith, C. E. Dunk, J. D. Aplin, L. K. Harris, and R. L. Jones Evidence for Immune Cell Involvement in Decidual Spiral Arteriole Remodeling in Early Human Pregnancy Am. J. Pathol., May 1, 2009; 174(5): 1959 - 1971. [Abstract] [Full Text] [PDF]

				C.-H. Tang, C.-S. Wu, T.-H. Lee, S.-T. Hung, C.-Y. C. Yang, C.-H. Lee, and P.-H. Chu Preeclampsia-Eclampsia and the Risk of Stroke Among Peripartum in Taiwan Stroke, April 1, 2009; 40(4): 1162 - 1168. [Abstract] [Full Text] [PDF]

				W. Chen and R. A. Khalil Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1962 - R1972. [Abstract] [Full Text] [PDF]

				F. M. Faraci Surviving the Remodel: The Impact of Hypertension During Pregnancy Hypertension, April 1, 2008; 51(4): 995 - 996. [Full Text] [PDF]